Innoplexus offers Data as a Service and Continuous Analytics as a Service products, leveraging Artificial Intelligence and advanced analytics to help reduce the drug development time, from synthesis to approval, significantly.  Our products leverage proprietary algorithms and patent pending technologies to help global Life Sciences and Pharmaceuticals organisations with access to relevant data, real time intelligence & intuitive insights, across pre-clinical, clinical, regulatory and commercial stages of a drug.  We automate the collection, curation, aggregation and analysis, of billions of data points from thousands of data sources, using machine learning, network analysis, ontologies, computer vision and entity normalisation.

Company profile: